Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances A Shepherd

Showing results (81-90 of 384) with videos related to

Pageof 39
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 7, 2012
Adjuvant chemotherapy for non-small cell lung cancer: practice patterns and outcomes in the general population of Ontario, CanadaChristopher M Booth, Frances A Shepherd, Yingwei Peng, et al.
The Oncologist|February 18, 2009
The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studiesGiorgio Scagliotti, Nasser Hanna, Frank Fossella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2015
NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell CarcinomaDavid W Cescon, Desmond She, Shingo Sakashita, et al.
Lancet (London, England)|May 14, 2011
Non-small-cell lung cancerPeter Goldstraw, David Ball, James R Jett, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Clinical utility of epidermal growth factor receptor expression for selecting patients with advanced non-small cell lung cancer for treatment with erlotinibGary M Clark, Denni M Zborowski, Jennifer L Culbertson, et al.
Radiology|July 11, 2018
Importance of Long-term Low-Dose CT Follow-up after Negative Findings at Previous Lung Cancer ScreeningJohn Kavanagh, Geoffrey Liu, Ravi Menezes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
KIF14 messenger RNA expression is independently prognostic for outcome in lung cancerTimothy W Corson, Chang Qi Zhu, Suzanne K Lau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
Adoption of adjuvant chemotherapy for non-small-cell lung cancer: a population-based outcomes studyChristopher M Booth, Frances A Shepherd, Yingwei Peng, et al.
Cancer|September 19, 2002
Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North AmericaPasi A Jänne, Boris Freidlin, Scott Saxman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 15, 2010
Derivation of utility values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 questionnaire values in lung cancerRaymond W Jang, Pierre K Isogai, Nicole Mittmann, et al.
Pageof 39

Showing results (81-90 of 384) with videos related to

Sort By:
Pageof 39
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 7, 2012
Adjuvant chemotherapy for non-small cell lung cancer: practice patterns and outcomes in the general population of Ontario, CanadaChristopher M Booth, Frances A Shepherd, Yingwei Peng, et al.
The Oncologist|February 18, 2009
The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studiesGiorgio Scagliotti, Nasser Hanna, Frank Fossella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2015
NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell CarcinomaDavid W Cescon, Desmond She, Shingo Sakashita, et al.
Lancet (London, England)|May 14, 2011
Non-small-cell lung cancerPeter Goldstraw, David Ball, James R Jett, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Clinical utility of epidermal growth factor receptor expression for selecting patients with advanced non-small cell lung cancer for treatment with erlotinibGary M Clark, Denni M Zborowski, Jennifer L Culbertson, et al.
Radiology|July 11, 2018
Importance of Long-term Low-Dose CT Follow-up after Negative Findings at Previous Lung Cancer ScreeningJohn Kavanagh, Geoffrey Liu, Ravi Menezes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
KIF14 messenger RNA expression is independently prognostic for outcome in lung cancerTimothy W Corson, Chang Qi Zhu, Suzanne K Lau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
Adoption of adjuvant chemotherapy for non-small-cell lung cancer: a population-based outcomes studyChristopher M Booth, Frances A Shepherd, Yingwei Peng, et al.
Cancer|September 19, 2002
Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North AmericaPasi A Jänne, Boris Freidlin, Scott Saxman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 15, 2010
Derivation of utility values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 questionnaire values in lung cancerRaymond W Jang, Pierre K Isogai, Nicole Mittmann, et al.
Pageof 39